Application of lower limb exoskeleton robots in elderly patients with ICU-acquired weakness: a prospective clinical study

下肢外骨骼机器人在ICU获得性肌无力老年患者中的应用:一项前瞻性临床研究

阅读:3

Abstract

OBJECTIVE: This study aimed to investigate the application effects of lower-limb exoskeleton robots in elderly patients with intensive care unit-acquired weakness (ICU-AW). METHODS: A total of 114 elderly patients with ICU-AW admitted to Yangzhou Second People’s Hospital between May 2023 and May 2025 were enrolled and randomly assigned using a random number table to either a control group (n = 57) or an experimental group (n = 57). The control group received conventional rehabilitation interventions, while the experimental group underwent lower-limb exoskeleton robot-assisted training in addition to conventional rehabilitation. Outcome measures compared before and after the intervention included scores on the Chelsea Critical Care Physical Assessment Tool (CPAx), Medical Research Council (MRC) muscle strength scale, and Barthel Index (BI); muscle quality parameters (fat fraction, cross-sectional area, T2 mapping); bone mineral density (T-score and classification); serum levels of creatine kinase (CK), osteocalcin (OC), and alkaline phosphatase (ALP); and the incidence of complications. RESULTS: Compared with baseline, both groups showed significant increases in CPAx, MRC, and BI scores, muscle cross-sectional area, T-scores, and serum OC levels, along with significant decreases in fat fraction, muscle water content T2, prevalence of osteoporosis, and serum CK and ALP levels (all P < 0.05). The improvements in all these outcome measures were significantly greater in the experimental group than in the control group (all P < 0.05). The overall complication rate was significantly lower in the experimental group [7.02% (4/57)] compared with the control group [21.05% (12/57)] (P = 0.031). CONCLUSION: Rehabilitation training using a lower-limb exoskeleton robot effectively improved muscle quality and bone mineral density in patients with ICU-AW, promoted physical functional recovery, enhanced quality of life, and demonstrated a favorable safety profile. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12877-026-07259-3.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。